Krichevsky, Anna M <br/><br/>
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond.  [electronic resource] 

 -  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics  04 2019 
 - 319-347 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1878-7479 
<br/><br/><label>Standard No.: </label>10.1007/s13311-018-00702-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Neoplasms--drug therapy<br/>Glioblastoma--drug therapy<br/>Humans<br/>MicroRNAs--genetics<br/>Molecular Targeted Therapy<br/>Mutation<br/>Oligonucleotides--therapeutic use<br/>RNA, Long Noncoding--genetics